WAKAMOTO PHARMACEUTICAL CO.,LTD. (4512)

Market cap
¥11.8B
P/E ratio
51.4x
Wakamoto Pharmaceutical manufactures branded drugs, generic medicines, and health products like Koryoku Wakamoto for healthcare providers and consumers in Japan and internationally.
Period EndMarketable securities, non-current (Million JPY)YoY (%)
Mar 31, 20262,253+21.90%
Mar 31, 20251,848-24.33%
Mar 31, 20242,442-1.66%
Mar 31, 20232,483+20.18%
Mar 31, 20222,066-16.21%
Mar 31, 20212,466+2.27%
Mar 31, 20202,411-8.47%
Mar 31, 20192,634-6.75%
Mar 31, 20182,825+8.85%
Mar 31, 20172,595-4.64%
Mar 31, 20162,722-4.98%
Mar 31, 20152,864
AI Chat